PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23706365-0	2013	Effects of enalapril on the expression of cardiac angiotensin-converting enzyme and angiotensin-converting enzyme 2 in spontaneously hypertensive rats.	Enalapril	11-20	angiotensin I converting enzyme 2	Rattus norvegicus	84-115	
25575522-7	2014	Enalapril also improved the cardiac parameters with a rise in cardiac ACE2, but did not change the Mas level.	Enalapril	0-9	angiotensin I converting enzyme 2	Rattus norvegicus	70-74	
23706365-8	2013	After treatment with enalapril, the levels of ACE mRNA and protein were decreased (0.44+-0.19 vs. 1.68+-0.34, P<0.01 and 0.87+-0.13 vs. 1.21+-0.14, P<0.05, respectively), the level of ACE2 mRNA was increased (1.77+-0.49 vs. 0.50+-0.15, P<0.05) but the level of ACE2 protein remained unchanged.	Enalapril	21-30	angiotensin I converting enzyme 2	Rattus norvegicus	190-194	
23706365-8	2013	After treatment with enalapril, the levels of ACE mRNA and protein were decreased (0.44+-0.19 vs. 1.68+-0.34, P<0.01 and 0.87+-0.13 vs. 1.21+-0.14, P<0.05, respectively), the level of ACE2 mRNA was increased (1.77+-0.49 vs. 0.50+-0.15, P<0.05) but the level of ACE2 protein remained unchanged.	Enalapril	21-30	angiotensin I converting enzyme 2	Rattus norvegicus	270-274	
23706365-10	2013	Reduction of ACE and elevation of ACE2 might be one of the mechanisms underlying the antihypertensive function of enalapril.	Enalapril	114-123	angiotensin I converting enzyme 2	Rattus norvegicus	34-38	
16908757-8	2006	Thus, the decrease in ACE2 expression and activity and circulating Ang-(1-9) levels in late ventricular dysfunction post-myocardial infarction were prevented with enalapril.	Enalapril	163-172	angiotensin I converting enzyme 2	Rattus norvegicus	22-26	
16908757-0	2006	Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.	Enalapril	0-9	angiotensin I converting enzyme 2	Rattus norvegicus	39-70	
16908757-7	2006	Enalapril prevented cardiac hypertrophy and dysfunction as well as the changes in left ventricular ACE, left ventricular and plasmatic ACE2, and circulating levels of Ang II and Ang-(1-9) after 8 weeks postinfarction.	Enalapril	0-9	angiotensin I converting enzyme 2	Rattus norvegicus	135-139	
33447763-5	2020	A similar pattern of ACE2 expression was found following the in vitro treatments of rat primary cells with captopril and enalapril.	Enalapril	121-130	angiotensin I converting enzyme 2	Rattus norvegicus	21-25	
32799423-6	2020	ACE2 was increased with only a few of the tested medication groups, namely the renin-angiotensin inhibitors, such as enalapril, antibacterial agents, such as nitrofurantoin, and the proton pump inhibitor, omeprazole.	Enalapril	117-126	angiotensin I converting enzyme 2	Rattus norvegicus	0-4